The Jehovah’s Witnesses have partly eased their long-standing prohibition on the medical use of donated blood, allowing ...
The U.S. is working on rules for investing in China that would likely preserve pharma's ability to strike most licensing ...
We’re very actively hiring,” Karim Mikhail, director of FDA’s Center for Biologics Evaluation and Research, told drug ...
Kennedy Jr. named eight new members to the U.S. Preventive Services Task Force, an influential panel of experts who assess ...
The lawsuit seeks to halt the process of searching grant applications for specific terms to determine if they should be ...
As part of broad drug pricing deals with the Trump administration, more than two dozen pharma companies agreed to sell drugs to state Medicaid programs at prices available in peer countries under ...
Over the past 25 years, there’s been a dramatic change in how we understand children who don’t “listen,” writes behavioral ...
The FDA approved a new gene therapy for Sanfilippo syndrome type A, an ultra-rare disease sometimes known as childhood ...
A breast cancer drug from AstraZeneca will now be available in England after a pricing deal was reached, in part a result of ...
The young men in my clinic are responding rationally to a system that was designed for profit,” writes plastic surgeon Kavitha Ranganathan.
Cautious optimism in the Ebola outbreak, FDA still stymied by DOGE cuts, and other health updates from the Morning Rounds ...
James Deardorff, a geriatrician at UCSF, talks about the benefits and pitfalls of using AI to make care decisions for older ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results